SCA
CNMD icon

Snowden Capital Advisors’s CONMED CNMD Stock Holding History

Snowden Capital Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,515
Closed -$275K – 1179
2023
Q4 		$275K Buy
2,515
+336
+15% +$34.7K 0.01% 933
2023
Q3 		$220K Sell
2,179
-200
-8% -$23K 0.01% 976
2023
Q2 		$323K Sell
2,379
-155
-6% -$18.9K 0.01% 929
2023
Q1 		$263K Buy
2,534
+133
+6% +$12.9K 0.01% 987
2022
Q4 		$213K Buy
+2,401
New +$199K 0.01% 1043
2022
Q3 		– Sell
-2,342
Closed -$224K – 1121
2022
Q2 		$224K Buy
2,342
+315
+16% +$37.8K 0.01% 995
2022
Q1 		$301K Buy
+2,027
New +$283K 0.01% 820

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Snowden Capital Advisors's CNMD Position: Q1 2024 in Review

Snowden Capital Advisors sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,515 shares — an estimated $275K sold.

Snowden Capital Advisors first reported a position in CNMD in Q1 2022 and held it in 7 quarters. The position peaked at $323K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Snowden Capital Advisors reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 2,515 CONMED shares in Q1 2024, an estimated $275K.
  • Snowden Capital Advisors first reported a position in CONMED in Q1 2022 and held it in 7 quarters.
  • Snowden Capital Advisors's CONMED position peaked at $323K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Snowden Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.